Gileads escapes liability in hepatitis C patent fight with Merck

NEW YORK, June 6 (Reuters) - A U.S. judge on Monday found a

pattern of misconduct by Merck & Co including lying

under oath and other unethical practices, freeing Gilead

Sciences Inc from paying any...

Read more